ART-123: Recombinant Human Soluble Thrombomodulin
Author:
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1527-3466.2000.tb00055.x/fullpdf
Reference57 articles.
1. Effects of recombinant human soluble thrombomodulin (rhs-TM) on disseminated intravascular coagulation model in the rats with decreased plasma antithrombin III level;Aoki;Thromb Haemost,1994
2. Antithrombotic effects of recombinant human soluble thrombomodulin (rhs-TM) on arteriovenous shunt thrombosis in rats;Aoki;Am J Hematol,1994
3. Recombinant human soluble thrombomodulin delivers bounded thrombin to antithrombin III: Thrombomodulin associates with free thrombin and is recycled to activate protein C;Aritomi;Thromb Haemost,1993
4. Kininase and vascular responses to kinins;Babiuk;Eur J Pharmacol,1982
5. TAFI, or plasma carboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex;Bajzar;J Biol Chem,1996
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A novel homozygous variant of the thrombomodulin gene causes a hereditary bleeding disorder;Blood Advances;2021-09-02
2. Influence of recombinant human-soluble thrombomodulin on extracorporeal circuit clotting in septic patients undergoing blood purification: a propensity-matched cohort study;Journal of Artificial Organs;2021-04-15
3. Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET;Annals of Intensive Care;2021-03-31
4. A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy;Cancer Chemotherapy and Pharmacology;2020-09-23
5. Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity;European Journal of Pharmacology;2020-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3